Concentration of Sales and Accounts Receivable Among Certain Customers
First written in FY2016. 8 of 17 entries say "Restated". Latest entry: FY2026.
Kidswell Bio moved to the "Worse" side of this theme in 2019, 4 years before the typical company in this theme (2023).
The whole theme swung hardest in 2017: 12 of 76 companies on the "Worse" side.
28 other companies' latest entry also says "Worsened".
- FY2026WorsenedAnnual report
「At the end of the consolidated fiscal year, 86.6% of trade receivables were attributable to a specific major customer.」
The proportion of trade receivables concentrated with a specific major customer increased from 57.4% in FY2025 to 86.6%. - FY2025SoftenedAnnual report
「At the end of the consolidated fiscal year, 57.4% of trade receivables were attributable to a specific major customer.」
The proportion of trade receivables concentrated with a specific major customer declined from 69.4% in FY2023 to 57.4%. However, dependence remained high in terms of sales, with Senju Pharmaceutical Co., Ltd. accounting for 55.7% and Mochida Pharmaceutical Co., Ltd. for 32.5%. - FY2023WorsenedAnnual report
「At the end of the fiscal year, 69.4% of trade receivables were attributable to a specific major customer.」
The proportion of trade receivables concentrated with a specific major customer increased from 52.1% in the previous fiscal year to 69.4%, indicating a higher concentration. - FY2023-Q3RestatedAnnual report
「During the cumulative third-quarter period, there were no new business risks and no material changes in the business risks described in the annual securities report for the preceding fiscal year.」
The company disclosed that there had been no material change in the risk of concentration of sales and accounts receivable among specific customers. - FY2022SoftenedAnnual report
「As of the consolidated settlement date for the fiscal year, 52.1% of trade receivables were attributable to a specific major customer.」
The proportion of trade receivables concentrated with a specific major customer declined from 96.4% in the previous fiscal year to 52.1%, easing the concentration. However, the customer still accounted for more than half. - FY2021WorsenedAnnual report
「As of the consolidated settlement date for the fiscal year, 96.4% of trade receivables were attributable to a specific major customer.」
The proportion of trade receivables concentrated with a specific major customer increased from 86.1% in the previous consolidated fiscal year to 96.4%, indicating a higher concentration. - FY2020SoftenedAnnual report
「As of the consolidated settlement date for the fiscal year, 86.1% of trade receivables were attributable to a specific major customer」
The proportion of trade receivables concentrated with a specific major customer was 86.1%, down from 99.8% previously. Although the disclosure also refers to a broader customer base, including Company A, dependence remained high. - FY2019WorsenedAnnual report
「As of the settlement date for the fiscal year, 99.8% of trade receivables were attributable to a specific major customer」
The proportion of trade receivables concentrated with a specific major customer increased from 90.7% in the previous fiscal year to 99.8%, indicating a higher concentration. - FY2019-Q1RestatedAnnual report
「During the cumulative first-quarter period, there were no new business or other risks and no material changes to the business or other risks described in the annual securities report for the previous fiscal year.」
The company disclosed that there had been no material change in the risk of concentration of sales and accounts receivable among specific customers. - FY2018RestatedAnnual report
「As of the settlement date for the fiscal year, 90.7% of trade receivables were attributable to a specific major customer」
The proportion of trade receivables concentrated with a specific major customer was 90.7%, maintaining a high level of dependence broadly in line with the previous fiscal year's 90.6%. - FY2018-Q3RestatedAnnual report
「During the nine months ended September, there were no new business or other risks, nor any material changes to the business or other risks described in the securities report for the prior fiscal year.」
The company disclosed that there had been no material change in the risk of concentration of sales and accounts receivable among specific customers. - FY2018-Q2RestatedAnnual report
「During the six months ended June, there were no new business or other risks, nor any material changes to the business or other risks described in the securities report for the prior fiscal year.」
The company disclosed that there had been no material change in the risk of concentration of sales and accounts receivable among specific customers. - FY2017SoftenedAnnual report
「As of the settlement date for the fiscal year, 90.6% of trade receivables were attributable to a specific major customer」
The proportion of trade receivables concentrated with a specific major customer declined from 100.0% previously to 90.6%. However, the company explained that its level of dependence remained extremely high. - FY2017-Q3RestatedAnnual report
「During the nine months ended September, there were no new business or other risks, nor any material changes to the business or other risks described in the securities report for the prior fiscal year.」
The company disclosed that there had been no material change in the risk of concentration of sales and accounts receivable among specific customers. - FY2017-Q2RestatedAnnual report
「During the six months ended June, there were no new business or other risks, nor any material changes to the business or other risks described in the securities report for the prior fiscal year.」
The company disclosed that there had been no new occurrence or material change in the risk of concentration of sales and accounts receivable among specific customers. - FY2017-Q1RestatedAnnual report
「Because the company has a small number of transactions and the transaction value per transaction is large, balances at the end of each quarterly accounting period tend to fluctuate significantly depending on transaction activity immediately before the period-end.」
The company continues to explain the volatility of accounts receivable balances arising from a small number of large transactions. - FY2016First statedAnnual report
「As of the settlement date for the fiscal year, 100.0% of trade receivables were attributable to a specific major customer」
The primary customer for current-period sales was Fuji Pharma Co., Ltd., and the company disclosed that the limited number of customers and termination of contracts could have a material impact on its operating results.